Related references
Note: Only part of the references are listed.First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma
Andrew X. Zhu et al.
CLINICAL CANCER RESEARCH (2013)
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
Mingqian Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Points of Therapeutic Intervention Along the Wnt Signaling Pathway in Hepatocellular Carcinoma
Sarah B. Nambotin et al.
Anti-Cancer Agents in Medicinal Chemistry (2012)
Silencing glypican-3 expression induces apoptosis in human hepatocellular carcinoma cells
Shiyuan Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3
Na Huang et al.
FEBS LETTERS (2012)
Crystal Structure of N-Glycosylated Human Glypican-1 Core Protein STRUCTURE OF TWO LOOPS EVOLUTIONARILY CONSERVED IN VERTEBRATE GLYPICAN-1
Gabriel Svensson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening
Yen Phung et al.
MABS (2012)
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
Austin Gurney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Human Monoclonal Antibodies to Sialyl-Lewisa (CA19.9) with Potent CDC, ADCC, and Antitumor Activity
Ritsuko Sawada et al.
CLINICAL CANCER RESEARCH (2011)
Glypican-3: A new target for cancer immunotherapy
Mitchell Ho et al.
EUROPEAN JOURNAL OF CANCER (2011)
A novel high-affinity human monoclonal antibody to mesothelin
Mitchell Ho et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitro
Mingqian Feng et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin
Wei Wei et al.
MOLECULAR CANCER (2011)
M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis
He Zhou et al.
PLOS ONE (2011)
Structure of the protein core of the glypican Dally-like and localization of a region important for hedgehog signaling
Min-Sung Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-β2
Chris K. Sun et al.
NEOPLASIA (2011)
Sulfation of heparan sulfate associated with amyloid-β plaques in patients with Alzheimer's disease
Ilona B. Bruinsma et al.
ACTA NEUROPATHOLOGICA (2010)
Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies
Seth A. Ettenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
Hirofumi Shirakawa et al.
CANCER SCIENCE (2009)
ScFv Antibody-induced Translocation of Cell-surface Heparan Sulfate Proteoglycan to Endocytic Vesicles EVIDENCE FOR HEPARAN SULFATE EPITOPE SPECIFICITY AND ROLE OF BOTH SYNDECAN AND GLYPICAN
Anders Wittrup et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
Wei Wei et al.
MOLECULAR CANCER (2009)
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma
A. Bengochea et al.
BRITISH JOURNAL OF CANCER (2008)
Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
Takahiro Ishiguro et al.
CANCER RESEARCH (2008)
PI-88: a novel inhibitor of angiogenesis
Ragini Kudchadkar et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
PI-88 and novel heparan sulfate mimetics inhibit angiogenesis
Vito Ferro et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
The soluble Wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo
Venita I. DeAlmeida et al.
CANCER RESEARCH (2007)
Heparan sulphate proteoglycans fine-tune mammalian physiology
Joseph R. Bishop et al.
NATURE (2007)
Wnt/frizzled signaling in hepatocellular carcinoma
HC Lee et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling
MI Capurro et al.
CANCER RESEARCH (2005)
Novel heparan sulfate structures revealed by monoclonal antibodies
J van den Born et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Wnt-3a-dependent cell motility involves RhoA activation and is specifically regulated by dishevelled-2
Y Endo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Vascular development in the retina and inner ear: Control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair
Q Xu et al.
CELL (2004)
Roles of heparan-sulphate glycosaminoglycans in cancer
R Sasisekharan et al.
NATURE REVIEWS CANCER (2002)
Share Paper
